NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.70 +0.68 (+0.87%) GOLD FUTURES
2,391.20 +31.30 (+1.33%) DOW
39,822.84 +264.73 (+0.67%) Bitcoin GBP
51,550.16 +3,134.65 (+6.47%)
Kymera Therapeutics, Inc. (KYMR)
| Previous close | 35.09 |
| Open | 36.17 |
| Bid | 35.31 x 100 |
| Ask | 45.12 x 200 |
| Day's range | 35.21 - 36.91 |
| 52-week range | 9.60 - 45.31 |
| Volume | |
| Avg. volume | 597,500 |
| Market cap | 2.376B |
| Beta (5Y monthly) | 2.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.51 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 51.07 |
GlobeNewswireKymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
Abstract released today highlights safety, pharmacodynamic and clinical response data collected through February 6, 2024 cut-off date Updated data to be presented at the European Hematology Association (EHA) Annual Meeting KT-333 Phase 1 study ongoing with additional data expected in the second half of 2024 WATERTOWN, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using
- GlobeNewswire
Kymera Therapeutics to Participate in Upcoming May Investor Conferences
WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events: BofA Securities 2024 Health Care Conference in Las Vegas, NV on May 15 at 4:20 p.m. PT; andTD Cowen 5th Annual Oncology Innovation Virtual Summit on May 28 at 1:
Simply Wall St.Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
It's been a pretty great week for Kymera Therapeutics, Inc. ( NASDAQ:KYMR ) shareholders, with its shares surging 12...
